Natalizumab-associated progressive multifocal leukoencephalopathy: successful treatment without plasma exchange and its associated risks

被引：0
|
作者：
Eimer Maloney
Anna Molloy
Mariam Al Hussona
Luke O’Donnell
Ronan Killeen
Christopher McGuigan
机构：
[1] St. Vincent’s University Hospital,Department of Neurology
[2] St. Vincent’s University Hospital,Department of Radiology
来源：
Journal of Neurology | 2017年 / 264卷
关键词：
Multiple Sclerosis; Multiple Sclerosis Patient; Progressive Multifocal Leukoencephalopathy; Mefloquine; Natalizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：401 / 403
页数：2
相关论文
共 50 条
  • [21] Determinants of clinical outcomes for patients with Natalizumab-associated progressive multifocal leukoencephalopathy
    Kappos, L.
    Mcguigan, C.
    Derfuss, T.
    Giovannoni, G.
    Oh, J.
    Ren, Z.
    McCarthy, K.
    Chang, I.
    Campbell, N.
    Ho, P. -R.
    Mason, L.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 19 - 20
  • [22] Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy
    Decard, Bernhard F.
    Haghikia, Aiden
    Toennes, Christina
    Thoene, Jan
    Lukas, Carsten
    Chan, Andrew
    Gold, Ralf
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (02) : 249 - 251
  • [23] Overview of Clinical Outcomes in Cases of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
    Gold, Ralf
    Foley, John
    Vermersch, Patrick
    Kappos, Ludwig
    Olsson, Tomas
    Cadavid, Diego
    Bozic, Carmen
    Richman, Sandra
    NEUROLOGY, 2011, 76 (09) : A636 - A636
  • [24] Re-evaluating the incidence of natalizumab-associated progressive multifocal leukoencephalopathy
    Borchardt, Julian
    Berger, Joseph R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 8 : 145 - 150
  • [25] Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy
    Tuan Dong-Si
    Gheuens, Sarah
    Gangadharan, Amy
    Wenten, Made
    Philip, Jeffrey
    McIninch, James
    Datta, Shoibal
    Richert, Nancy
    Bozic, Carmen
    Bloomgren, Gary
    Richman, Sandra
    Weber, Thomas
    Clifford, David B.
    JOURNAL OF NEUROVIROLOGY, 2015, 21 (06) : 637 - 644
  • [26] Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy
    Hoepner, Robert
    Kolb, Eva M.
    Dahlhaus, Stefanie
    Hellwig, Kerstin
    Adams, Ortwin
    Kleiter, Ingo
    Salmen, Anke
    Schneider, Ruth
    Lukas, Carsten
    Chan, Andrew
    Berger, Joseph R.
    Gold, Ralf
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (06) : 830 - 835
  • [27] A Case of Natalizumab-associated Progressive Multifocal Leukoencephalopathy—Role for Advanced MRI?
    M. Berghoff
    B. Dassinger
    J. Iwinska-Zelder
    M. Giraldo
    S. Bilgin
    M. Kaps
    E. R. Gizewski
    Clinical Neuroradiology, 2014, 24 : 173 - 176
  • [28] Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy
    G. Classen
    C. Classen
    C. Bernasconi
    C. Brandt
    R. Gold
    A. Chan
    R. Hoepner
    Journal of NeuroVirology, 2019, 25 : 133 - 136
  • [29] Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy
    Hoepner, Robert
    Dahlhaus, Stefanie
    Kollar, Susanne
    Zurawski, Barbara
    Chan, Andrew
    Kleiter, Ingo
    Gold, Ralf
    Hellwig, Kerstin
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2014, 7 (01) : 3 - 6
  • [30] Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy
    Classen, G.
    Classen, C.
    Bernasconi, C.
    Brandt, C.
    Gold, R.
    Chan, A.
    Hoepner, R.
    JOURNAL OF NEUROVIROLOGY, 2019, 25 (01) : 133 - 136
12345